Home/Exuma Biotechnology/Wendy Li, M.D.
WL

Wendy Li, M.D.

Chief Medical Officer

Exuma Biotechnology

Exuma Biotechnology Pipeline

DrugIndicationPhase
Autologous HER2 Directed TMR CAR-TSolid Tumors (e.g., GI Cancers)Phase 1